These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12665412)

  • 1. The therapeutic potential of cannabis in multiple sclerosis.
    Baker D; Pryce G
    Expert Opin Investig Drugs; 2003 Apr; 12(4):561-7. PubMed ID: 12665412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards cannabis and cannabinoid treatment of multiple sclerosis.
    Croxford JL; Miller SD
    Drugs Today (Barc); 2004 Aug; 40(8):663-76. PubMed ID: 15510238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The endocannabinoid system and multiple sclerosis.
    Baker D; Pryce G
    Curr Pharm Des; 2008; 14(23):2326-36. PubMed ID: 18781983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging properties of cannabinoid medicines in management of multiple sclerosis.
    Pryce G; Baker D
    Trends Neurosci; 2005 May; 28(5):272-6. PubMed ID: 15866202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis and cannabinoids: pharmacology and rationale for clinical use.
    Pertwee RG
    Forsch Komplementarmed; 1999 Oct; 6 Suppl 3():12-5. PubMed ID: 10575283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoids control spasticity and tremor in a multiple sclerosis model.
    Baker D; Pryce G; Croxford JL; Brown P; Pertwee RG; Huffman JW; Layward L
    Nature; 2000 Mar; 404(6773):84-7. PubMed ID: 10716447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cannabinoids in multiple sclerosis.
    Zajicek JP; Apostu VI
    CNS Drugs; 2011 Mar; 25(3):187-201. PubMed ID: 21323391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
    Rice J; Cameron M
    Curr Neurol Neurosci Rep; 2018 Jun; 18(8):50. PubMed ID: 29923025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The therapeutic potential of cannabis.
    Baker D; Pryce G; Giovannoni G; Thompson AJ
    Lancet Neurol; 2003 May; 2(5):291-8. PubMed ID: 12849183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of cannabinoids in CNS disease.
    Croxford JL
    CNS Drugs; 2003; 17(3):179-202. PubMed ID: 12617697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cannabinoids for symptomatic therapy of multiple sclerosis].
    Husseini L; Leussink VI; Warnke C; Hartung HP; Kieseier BC
    Nervenarzt; 2012 Jun; 83(6):695-704. PubMed ID: 22080198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoids and neuroprotection.
    Grundy RI; Rabuffetti M; Beltramo M
    Mol Neurobiol; 2001; 24(1-3):29-51. PubMed ID: 11831553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [News about therapeutic use of Cannabis and endocannabinoid system].
    Duran M; Laporte JR; Capellà D
    Med Clin (Barc); 2004 Mar; 122(10):390-8. PubMed ID: 15033046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids and multiple sclerosis.
    Pertwee RG
    Pharmacol Ther; 2002 Aug; 95(2):165-74. PubMed ID: 12182963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid control of neuroinflammation related to multiple sclerosis.
    Baker D; Jackson SJ; Pryce G
    Br J Pharmacol; 2007 Nov; 152(5):649-54. PubMed ID: 17891167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential control of multiple sclerosis by cannabis and the endocannabinoid system.
    Pryce G; Baker D
    CNS Neurol Disord Drug Targets; 2012 Aug; 11(5):624-41. PubMed ID: 22583441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews.
    Nielsen S; Germanos R; Weier M; Pollard J; Degenhardt L; Hall W; Buckley N; Farrell M
    Curr Neurol Neurosci Rep; 2018 Feb; 18(2):8. PubMed ID: 29442178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoids in the treatment of pain and spasticity in multiple sclerosis.
    Smith PF
    Curr Opin Investig Drugs; 2002 Jun; 3(6):859-64. PubMed ID: 12137404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabis and cannabinoid receptors.
    Nocerino E; Amato M; Izzo AA
    Fitoterapia; 2000 Aug; 71 Suppl 1():S6-12. PubMed ID: 10930707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis and the brain.
    Iversen L
    Brain; 2003 Jun; 126(Pt 6):1252-70. PubMed ID: 12764049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.